Navigation Links
Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development
Date:2/17/2009

al and international groups;
8. The promise and potential of this approach.

ABOUT DR. VON HOFF

A member of President Bush's National Cancer Advisory Board, Dr. Von Hoff's major interest is in the development of new anticancer agents both in the clinic and in the laboratory. His laboratory interests and contributions have been in the area of in vitro drug sensitivity testing to individualize treatment for the patient. At present, he and his colleagues are concentrating on the development of molecularly targeted therapies with a focus on pancreatic cancer.

Dr. Von Hoff currently serves as Senior Investigator and Head of Translational Research at the Translational Genomics Research Institute's (TGen) Translational Drug Development Division and Head, Pancreatic Cancer Research Program in Phoenix, Arizona. He also serves as Chief Scientific Officer for U.S. Oncology and the Scottsdale Clinical Research Institute and is a founding shareholder and chair of the medical advisory board of Medelis.

ABOUT "INSIDER ABSTRACTS"

The abstract is the fifth in Medelis' complimentary "Peer Perspectives in Oncology" Q&A series, which brings together respected researchers to discuss issues that face Chief Medical Officers today.

These free abstracts are available for download at Medelis.com.

ABOUT MEDELIS

Medelis, Inc. is an oncology contract research organizat
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development 
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... NV (PRWEB) September 01, 2014 ... and online marketers that was developed to automate the ... caught the attention of Shane Michaels, prompting an investigative ... entrepreneur, the daily duty of managing all of the ... can be quite overwhelming,” reports Michaels. “That’s why Ontraport ...
(Date:9/1/2014)... 31, 2014 Daily Gossip reveals in ... and community that gives members access to thousands of ... This online resource aims to help both people who ... artists who are looking for inspiration in creating one ... Tattoo Me Now by visiting the official website at: ...
(Date:9/1/2014)... The Outlier Series announced the next short e-Book ... one of the exceptional women featured in the series’ ... . The title of the upcoming mini e-Book is ... . McClendon is currently a full-time physician’s assistant, and ... WeTV show, Raising Sextuplets. , Jenny was chosen as ...
(Date:9/1/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on DePuy Synthes Craniomaxillofacial Distraction ... August 28, that specific lots of DePuy Synthes Craniomaxillofacial ... the device may reverse directions after surgery. According ... System is an implant used to lengthen and/or stabilize ...
Breaking Medicine News(10 mins):Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3
... 4 (HealthDay News) -- Rates of head and neck cancer ... without any known risk factors. Now, a study suggests that ... of precancerous cells in the mouth. Previous research ... the lungs are exposed to smoke. This may lead to ...
... study of its kind, a research team led by Michigan ... the most traumatic situations were less likely to suffer health ... surveyed Army troops fighting in Iraq, could have implications for ... events such as death. Training these first-responders to think in ...
... (RA) who are current smokers were less likely to achieve ... inhibitors than those who never smoked. The study by researchers ... the past did not experience a lower response to these ... 2011 issue of Arthritis & Rheumatism , a journal ...
... Amanda Gardner HealthDay Reporter , MONDAY, Jan. 3 ... cancer on the left side of the colon, new research ... right side. The finding contradicts some previous research that ... However, the right-side benefit shown in the new study, published ...
... FOR MODERATE TO SEVERE ASTHMA ... is safe and effective an add-on treatment to corticosteroids for ... Uruguay, Argentina, and Chile performed a meta-analysis on eight trials ... At the end of the steroid reduction phase, patients taking ...
... The rapid growth in use of medical diagnostic imaging, ... radiation exposure in adults and the potential for future cancer ... led by University of Michigan researchers now shows that kids ... routine clinical care, and highlights the importance of initiatives to ...
Cached Medicine News:Health News:Estrogen May Play Role in Rising Rates of Head, Neck Cancer 2Health News:MSU leads first study of resiliency on the battlefield 2Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 3Health News:News briefs from the January issue of Chest 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 2Health News:U-M study: Kids frequently exposed to medical imaging procedures that use radiation 3
(Date:8/30/2014)... , Aug. 30, 2014  Boston Scientific has ... Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, ... investigating vagus nerve stimulation (VNS) for the treatment ... Professor of Therapeutics and Cardiology and Director of ... de la Sante et de la Recherche Medicale ...
(Date:8/30/2014)... ANDOVER, Mass. , Aug. 30, 2014   ... launch of Affiniti, a new ultrasound system ... overcome the demands of increasing patient volumes and cost ... Cardiology (ESC) Congress 2014 in Barcelona ... radiology/ultrasound departments facing more patients with fewer resources deliver ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... A growing number of healthcare providers are choosing ... better control over non-file, off-contract spending, focusing on ... Suite, healthcare decision-makers receive sound content, accurate contract ... process, rather than after the fact. With greater ...
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) will ... Pharma Virtual Conference.  Interested parties can access the audio ... October 13, 2010 at 12:30 p.m. Eastern time, which ... About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals ...
Cached Medicine Technology:Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable 2Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable 3
... Series Pediatric Oxygen Flowmeters with Double ... chain, add suffix S to model ... Color-Code, add suffix C to model ... Flowmeters with Power Take-Off, add PT ...
... is designed specifically for detection of recent-onset ... macular perimeter maps and quantifies visual field ... ("dry") AMD to the wet stage of ... to compensate for small visual field defects, ...
... FVL is a new functional test which ... Activated Protein C Resistance caused by the ... to other commercially available methods, Pefakit APC-R ... or S, Lupus Anticoagulants, Elevated FVIII levels, ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
Medicine Products: